Tirzepatide is an active ingredient that targets two hormone receptors, GLP-1 and GIP, to reduce appetite, support blood sugar regulation, and promote weight loss
A common protocol for patients with a B12 deficiency may be 1,000 mcg daily for one week, then the same dosage once weekly, and then the same dosage once per month after the deficiency has been addressed
Krajewski PK, Matusiak , Szepietowski JC
Understanding Concerns of GLP-1 Weight Loss Treatment Glucagon-like peptide-1 (GLP-1) medications like Wegovy (semaglutide) and Zepbound (tirzepatide) can be an effective treatment for weight loss, helping people reduce the chance of weight-related complications and improve their overall health
This therapy is administered through small subcutaneous injections, similar to an insulin needle, typically in the abdomen, thigh, or upper arm